Skip to search formSkip to main contentSkip to account menu

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Known as: CLL/SLL 
An indolent (slow-growing) cancer in which immature lymphocytes (white blood cells) are found in the blood and bone marrow and/or in the lymph nodes… 
National Institutes of Health

Related topics

Related topics

14 relations
Atypical lymphocyteB lymphoblastB-LymphocytesFatigue

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
The impacts of zanubrutinib on immune cells in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma
Ibrutinib, a first‐generation Bruton's tyrosine kinase (BTK) inhibitor, could improve immunity of relapsed or refractory (R/R… 
Highly Cited
2018
Highly Cited
2018
PD-1 Expression in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) and Large B-cell Richter Transformation (DLBCL-RT): A Characteristic Feature of DLBCL-RT and Potential Surrogate…
Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) is a low-grade B-cell neoplasm and ∼2% to 9% patients develop… 
2015
2015
Chronic lymphocytic leukemia/small lymphocytic lymphoma, version 1.2015.
Chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) are different manifestations of the same disease, which… 
Review
2015
Review
2015
The many faces of small B cell lymphomas with plasmacytic differentiation and the contribution of MYD88 testing
Plasmacytic differentiation may occur in almost all small B cell lymphomas (SBLs), although it varies from being uniformly… 
Highly Cited
2013
Highly Cited
2013
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) are B-cell lymphoproliferative disorders characterized by… 
Highly Cited
2011
Highly Cited
2011
Nuclear overexpression of lymphoid-enhancer-binding factor 1 identifies chronic lymphocytic leukemia/small lymphocytic lymphoma in small B-cell lymphomas
Lymphoid-enhancer-binding factor 1 (LEF1), coupling with β-catenin, functions as a key nuclear mediator of WNT/β-catenin… 
Highly Cited
2003
Highly Cited
2003
Autoimmune cytopenia does not predict poor prognosis in chronic lymphocytic leukemia/small lymphocytic lymphoma †
Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) is characterized by an acquired immune defect that can cause… 
Highly Cited
2001
Highly Cited
2001
Value of CD23 determination by flow cytometry in differentiating mantle cell lymphoma from chronic lymphocytic leukemia/small lymphocytic lymphoma.
Mantle cell lymphoma (MCL) and chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) share many morphologic and… 
Highly Cited
2000
Highly Cited
2000
The chemokine receptor CXCR3 is expressed in a subset of B-cell lymphomas and is a marker of B-cell chronic lymphocytic leukemia.
Chemotaxis in leukocytes is mediated through binding of soluble chemokines to transmembrane G-protein coupled receptors. The… 
Highly Cited
1990
Highly Cited
1990
Association of bcl-1 rearrangements with lymphocytic lymphoma of intermediate differentiation.
Previous studies using classical cytogenetics have demonstrated the presence of the t(11;14) (q13;q32) chromosomal translocation… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)